Dr Sarah Richardson
Sarah Richardson’s career in type 1 diabetes research began in 2007 when she joined Professor Noel Morgan’s group at the University of Exeter Medical School. Prior to this her postdoctoral work was in the field of apoptosis based at both the University of Sheffield and the Walter and Eliza Hall Institute in Melbourne. She utilises two unique cohorts of type 1 diabetes patient pancreas samples and her research is centred around developing a clearer understanding of the disease processes by which beta cells are targeted and destroyed. She has a particular interest in the role that enteroviruses may play in the disease pathogenesis. Her current research projects are aimed at confirming whether enterovirus can be detected in the pancreas of patients, and enhancing knowledge of the pathogenic signaling mechanisms involved in the recruitment and activation of immune cells. The success of this work enabled her to gain a Diabetes Research Wellness Foundation (DRWF) Non-Clinical Research Fellowship, a Juvenile Diabetes Research Foundation (JDRF) Career Development Award, an nPOD Junior Investigator Award and she was an Innovators in Diabetes participant with Diabetes UK (2010-2013). She is an enthusiastic and pro-active member of both the nPOD-V, where she is also a Task leader, and the EU FP7 PEVNET networks.
- BSc (Hons) Molecular Biology 1st Class
|Tel||+44 (0) 1392 408225|
|Address||University of Exeter Medical School|
RD&E Hospital Wonford